| scholarly article | Q13442814 |
| P2093 | author name string | Thomas Christen | |
| Benjamin Lemasson | |||
| Christoph Segebarth | |||
| Régine Farion | |||
| Emmanuel L Barbier | |||
| Olivier Duchamp | |||
| Xavier Tizon | |||
| Chantal Remy | |||
| Peggy Provent | |||
| Nadège Fondraz | |||
| Philippe Genne | |||
| P2860 | cites work | Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy | Q29547379 |
| Role of angiogenesis in tumor growth and metastasis | Q29614309 | ||
| AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. | Q30490422 | ||
| A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients | Q30493217 | ||
| Methodology of brain perfusion imaging | Q30643023 | ||
| Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma | Q31015437 | ||
| Angiogenesis in gliomas: imaging and experimental therapeutics | Q31028310 | ||
| Diffusion-weighted MRI in the body: applications and challenges in oncology | Q31113294 | ||
| MRI of tumor angiogenesis | Q33290510 | ||
| Biomarkers of response and resistance to antiangiogenic therapy | Q34673567 | ||
| Rapid vascular regrowth in tumors after reversal of VEGF inhibition | Q35052385 | ||
| Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts | Q35102889 | ||
| Evaluation of cancer therapy using diffusion magnetic resonance imaging. | Q35157025 | ||
| Sorafenib exerts anti-glioma activity in vitro and in vivo | Q35414966 | ||
| High-resolution longitudinal assessment of flow and permeability in mouse glioma vasculature: Sequential small molecule and SPIO dynamic contrast agent MRI. | Q35625666 | ||
| Evaluation of the response to treatment of solid tumours - a consensus statement of the International Cancer Imaging Society | Q35776931 | ||
| Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI | Q35946168 | ||
| Discovery and development of sorafenib: a multikinase inhibitor for treating cancer. | Q36610990 | ||
| Angiogenesis in brain tumours | Q36887534 | ||
| Sorafenib inhibits signal transducer and activator of transcription 3 signaling associated with growth arrest and apoptosis of medulloblastomas | Q36992993 | ||
| High grade glioma: imaging combined with pathological grade defines management and predicts prognosis | Q37012633 | ||
| Bevacizumab and chemotherapy for recurrent glioblastoma: a single-institution experience | Q37180426 | ||
| Emerging antiangiogenic treatments for gliomas - efficacy and safety issues | Q37342619 | ||
| Dynamic MRI using iron oxide nanoparticles to assess early vascular effects of antiangiogenic versus corticosteroid treatment in a glioma model | Q37354846 | ||
| Primetime for antiangiogenic therapy | Q37604842 | ||
| Quantitative BOLD: mapping of human cerebral deoxygenated blood volume and oxygen extraction fraction: default state | Q37677183 | ||
| Assessment of blood volume, vessel size, and the expression of angiogenic factors in two rat glioma models: a longitudinal in vivo and ex vivo study. | Q39963091 | ||
| KRN951, a highly potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, has antitumor activities and affects functional vascular properties. | Q40230481 | ||
| Tumor microvascular changes in antiangiogenic treatment: assessment by magnetic resonance contrast media of different molecular weights. | Q40540980 | ||
| Assessment of vascular remodeling under antiangiogenic therapy using DCE-MRI and vessel size imaging. | Q44114516 | ||
| Time of death of CNS tumor-bearing rats can be reliably predicted by body weight-loss patterns | Q44235205 | ||
| Pilot study of DCE-MRI to predict progression-free survival with sorafenib therapy in renal cell carcinoma | Q46792167 | ||
| MR imaging assessment of the kinetics of P846, a new gadolinium-based MR contrast medium, in ischemically injured myocardium | Q46946838 | ||
| Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. | Q48797418 | ||
| Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model | Q72302287 | ||
| Neuroimaging in neuro-oncology | Q84135677 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 5 | |
| P921 | main subject | cytotoxicity | Q246181 |
| angiogenesis inhibitor | Q574834 | ||
| P304 | page(s) | 473-482 | |
| P577 | publication date | 2010-12-08 | |
| P1433 | published in | NMR in Biomedicine | Q3061252 |
| P1476 | title | Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and anti-angiogenic drug effects | |
| P478 | volume | 24 |
| Q30604706 | A simulation tool for dynamic contrast enhanced MRI. |
| Q37088411 | Assessing the reproducibility of dynamic contrast enhanced magnetic resonance imaging in a murine model of breast cancer |
| Q43447982 | Characterization of the 9L gliosarcoma implanted in the Fischer rat: an orthotopic model for a grade IV brain tumor. |
| Q39817583 | Characterization of the serum metabolome following radiation treatment in patients with high-grade gliomas |
| Q30930526 | Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors |
| Q26853308 | Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients |
| Q36500372 | Detection of glioblastoma response to temozolomide combined with bevacizumab based on μMRI and μPET imaging reveals [18F]-fluoro-L-thymidine as an early and robust predictive marker for treatment efficacy |
| Q37236015 | Diffusion-Weighted MRI as a Biomarker of Tumor Radiation Treatment Response Heterogeneity: A Comparative Study of Whole-Volume Histogram Analysis versus Voxel-Based Functional Diffusion Map Analysis |
| Q21560786 | Distribution and radiosensitizing effect of cholesterol-coupled Dbait molecule in rat model of glioblastoma |
| Q52654441 | Dynamic contrast-enhanced MRI in mouse tumors at 11.7 T: comparison of three contrast agents with different molecular weights to assess the early effects of combretastatin A4. |
| Q38314429 | Functional MRI and CT biomarkers in oncology |
| Q92602674 | Glioblastoma multiforme restructures the topological connectivity of cerebrovascular networks |
| Q46842885 | High-resolution cerebral blood volume imaging in humans using the blood pool contrast agent ferumoxytol. |
| Q38244289 | Imaging the microvessel caliber and density: Principles and applications of microvascular MRI. |
| Q33616649 | MRI biomarkers identify the differential response of glioblastoma multiforme to anti-angiogenic therapy |
| Q36852895 | MRI measurements of vessel calibre in tumour xenografts: comparison with vascular corrosion casting |
| Q38992908 | Microvascular MRI and unsupervised clustering yields histology-resembling images in two rat models of glioma. |
| Q53829611 | Multiparametric MRI as an early biomarker of individual therapy effects during concomitant treatment of brain tumours. |
| Q36033915 | Overexpression of miRNA-497 inhibits tumor angiogenesis by targeting VEGFR2. |
| Q36176340 | Perfluorocarbon-Loaded Lipid Nanocapsules to Assess the Dependence of U87-Human Glioblastoma Tumor pO2 on In Vitro Expansion Conditions |
| Q30575110 | Practical dynamic contrast enhanced MRI in small animal models of cancer: data acquisition, data analysis, and interpretation |
| Q42870267 | Tissue oxygen saturation mapping with magnetic resonance imaging. |
| Q30651792 | Vessel caliber--a potential MRI biomarker of tumour response in clinical trials. |
| Q39507583 | Vessel size index measurements in a rat model of glioma: comparison of the dynamic (Gd) and steady-state (iron-oxide) susceptibility contrast MRI approaches |
Search more.